ASCO in Action

ASCO in Action provides the latest news and analysis related to critical policy issues affecting the cancer community, updates on the Association for Clinical Oncology’s ongoing advocacy efforts, and opportunities for members and others in the cancer care community to take action.

To sign up for advocacy alerts, log in to with your member or guest account, and visit the subscription center available under your account profile.

Showing results for Advocacy

November 22, 2022

Prior authorization is harming individuals with cancer according to new survey results from the Association for Clinical Oncology (ASCO). The survey found that prior authorization delays necessary care, worsens cancer care outcomes, and diverts clinicians from caring for their patients.

November 22, 2022

Without congressional action before the end of the year, Medicare providers are set to face up to a 10% reimbursement cut. The Association for Clinical Oncology (ASCO) encourages its members to contact their lawmakers and urge them to address the cuts now.

November 16, 2022

From November 11-15, delegates from the Association for Clinical Oncology (ASCO) participated in the 2022 Interim Meeting of the American Medical Association’s (AMA) House of Delegates (HOD). The AMA HOD is the principal policy-making body of AMA and meets twice a year to discuss pressing issues and establish policies the AMA uses when setting their advocacy priorities.

ASCO led three resolutions during the meeting and cosponsored a fourth. All four resolutions passed.

November 8, 2022

The Centers for Medicare & Medicaid Services finalized changes to Medicare enrollment policy that will make Medicare Part A and Part B coverage effective sooner after an individual enrolls in the program, eliminating gaps or delays in coverage. The Association for Clinical Oncology advocated for these changes in comments on the “Implementing Certain Provisions of the Consolidated Appropriations Act, 2021” proposed rule.

November 1, 2022

On November 1, 2022, the Centers for Medicare & Medicaid Services (CMS) released its final rule for the calendar year (CY) 2023 Medicare Physician Fee Schedule and updates to the Quality Payment Program. CMS also released its final rule for the CY 2023 Hospital Outpatient Prospective Payment System the same day. The Association for Clinical Oncology (ASCO) is still assessing the rules, but based on a preliminary analysis, key provisions for the cancer care community are included here.

October 17, 2022

The Internal Revenue Service (IRS) recently finalized policy changes that make health care coverage more affordable for approximately one million individuals by fixing the so-called “family glitch.” The new policy updates the interpretation of the “affordability” of health insurance plans and allows eligible families to receive tax credits to buy more affordable insurance through an Affordable Care Act (ACA) exchange if employer coverage is too costly.  

October 4, 2022

On August 4, 2022, the Department of Health and Human Services (HHS) issued a proposed rule on Section 1557 (first finalized in May 2016) of the Affordable Care Act (ACA), which prohibits discrimination on the basis of race, color, national origin, sex, age, or disability in certain health programs and activities.

September 30, 2022

As expected in the lead-up to midterm elections, Congress today (September 30) passed a continuing resolution (CR) that funds the government through December 16, 2022, avoiding a government shutdown and giving Congress more time to negotiate critical funding decisions for Fiscal Year 2023.

September 27, 2022

In comments to the Centers for Medicare & Medicaid Services (CMS) on the 2023 Hospital Outpatient Prospective Payment System (OPPS) proposed rule, the Association for Clinical Oncology (ASCO) continues to call for a final rule that supports patient access to high-quality, equitable cancer care and support for oncology providers. Highlights from ASCO’s comments are includeded here.

September 27, 2022

In a step towards addressing one of multiple pending Medicare physician payment cuts, Representatives Ami Bera, MD (D-CA) and Larry Bucshon, MD (R-IN) introduced the Supporting Medicare Providers Act (H.R. 8800), which would increase the conversion factor to 4.42%, effectively putting the Medicare physician fee schedule cut on hold for a year. The new legislation also includes language that says lawmakers and the Department of Health and Human Services should work to promote and reward value-based care, as well as safeguard timely access to high-quality care by advancing health equity and reducing disparities. The Association for Clinical Oncology supports this effort to provide short-term stability and urges Congress to pass the bill before the end of the year.

September 14, 2022

UPDATE: On September 14, 2022, the House of Representatives passed the Improving Seniors’ Timely Access to Care Act (H.R. 3173) by voice vote on the House floor. The bill now moves to the Senate. This remains a critical moment when your Senators need to hear your support for this legislation. Please ask them to pass this bill into law—it takes seconds using the ACT Network. 

September 13, 2022

In a letter to the Centers for Medicare & Medicaid Services (CMS), the Association for Clinical Oncology (ASCO) comments on provisions in the 2023 Medicare Physician Fee Schedule (MPFS) and Quality Payment Program (QPP) proposed rule that would impact cancer care for Medicare beneficiaries.

September 12, 2022

“President John F. Kennedy’s historic speech that inspired our nation and an entire generation of Americans to achieve manned space exploration underscored the courage and commitment it would take to accomplish this then-audacious goal: ‘We choose to go to the moon in this decade and do the other things, not because they are easy, but because they are hard.’

September 8, 2022

This September leadership and advocates from the Association of Clinical Oncology (ASCO) are set to participate in various events commemorating Childhood Cancer Awareness Month.

September 6, 2022

Medicare providers are facing significant reimbursement cuts starting January 1. The 2023 Medicare Physician Fee Schedule proposal jeopardizes the financial stability of many oncology practices by proposing a cut to the Medicare conversion factor of approximately 4.5%. Urge Congress to pass important changes that will provide practices with short-term fiscal stability, while simultaneously laying the foundation for long-term payment reforms.